Cargando…

MicroRNA-130a Increases and Predicts Cardiotoxicity during Adjuvant Chemotherapy in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

PURPOSE: This study aimed to investigate the changes in microRNA-130a (miR-130a) and its correlation with cardiotoxicity during epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab (EC-D+T) adjuvant chemotherapy in human epidermal growth factor receptor-2-positive (HER2(+)) breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Qiang, Ren, Yanbin, Hou, Aijun, Guo, Jing, Mao, Zhezhe, Liu, Shaojun, Wang, Boya, Bai, Zhichao, Hou, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090801/ https://www.ncbi.nlm.nih.gov/pubmed/33818020 http://dx.doi.org/10.4048/jbc.2021.24.e15

Ejemplares similares

MicroRNA‐34a in coronary heart disease: Correlation with disease risk, blood lipid, stenosis degree, inflammatory cytokines, and cell adhesion molecules
por: Li, Hefei, et al.
Publicado: (2021)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
por: Visvikis, A, et al.
Publicado: (2020)

MicroRNAs in Cancer Treatment-Induced Cardiotoxicity
por: Pellegrini, Laura, et al.
Publicado: (2020)

Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy
por: Leger, Kasey J., et al.
Publicado: (2017)

Impact of microRNA-130a on the neutrophil proteome
por: Pedersen, Corinna Cavan, et al.
Publicado: (2015)

MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
por: Kuang, Ziyu, et al.
Publicado: (2023)

Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis
por: Ohtsu, Hiroshi, et al.
Publicado: (2022)

MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling
por: Xia, Wenzheng, et al.
Publicado: (2021)

MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
por: Kawano, Ippei, et al.
Publicado: (2022)

The Role of MicroRNAs in Epidermal Barrier
por: Lee, Ai-Young
Publicado: (2020)

Aging, cardiotoxicity, and chemotherapy
por: Bocchi, Edimar Alcides, et al.
Publicado: (2019)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
por: Piegari, Elena, et al.
Publicado: (2016)

Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
por: Alam, Salma, et al.
Publicado: (2018)

Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial
por: Advani, Pooja P., et al.
Publicado: (2023)

MicroRNA‐130a regulates neurological deficit and angiogenesis in rats with ischaemic stroke by targeting XIAP
por: Deng, Wenjing, et al.
Publicado: (2020)

Translational Control of FOG-2 Expression in Cardiomyocytes by MicroRNA-130a
por: Kim, Gene H., et al.
Publicado: (2009)

MicroRNA‐130a, a Potential Antifibrotic Target in Cardiac Fibrosis
por: Li, Li, et al.
Publicado: (2017)

MicroRNA-130a is highly expressed in the esophageal mucosa of achalasia patients
por: Shoji, Hiroyuki, et al.
Publicado: (2017)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors
por: Uprety, Dipesh, et al.
Publicado: (2020)

Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer
por: Erselcan, T, et al.
Publicado: (2000)

Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity
por: Course, Meredith M., et al.
Publicado: (2019)

microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
por: Henderson, John, et al.
Publicado: (2021)

microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer
por: Zhou, Yiran, et al.
Publicado: (2017)

XB130, a New Adaptor Protein, Regulates Expression of Tumor Suppressive MicroRNAs in Cancer Cells
por: Takeshita, Hiroki, et al.
Publicado: (2013)

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
por: Ruggeri, Clarissa, et al.
Publicado: (2017)

Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin‐induced cardiotoxicity
por: Beaumier, Amelie, et al.
Publicado: (2020)

MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
por: Totoń-Żurańska, Justyna, et al.
Publicado: (2022)

Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
por: Gillespie, Hamilton S, et al.
Publicado: (2011)

Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention
por: CSAPO, MELINDA, et al.
Publicado: (2014)

Pediatric Chemotherapy Drugs Associated With Cardiotoxicity
por: Hitawala, Gazala, et al.
Publicado: (2021)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
por: Viswanathan, Thyla, et al.
Publicado: (2021)

High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma
por: Wang, Wen-yao, et al.
Publicado: (2014)

Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma
por: Besse, Lenka, et al.
Publicado: (2015)

Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior in vitro
por: Wu, Yi, et al.
Publicado: (2018)

MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4()()
por: Ha Thi, Huyen Trang, et al.
Publicado: (2019)

MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression
por: Causin, Rhafaela Lima, et al.
Publicado: (2023)

Extracellular microRNA 130b‐3p inhibits eCIRP‐induced inflammation
por: Gurien, Steven D, et al.
Publicado: (2019)

microRNA-130a is an Oncomir Suppressing the Expression of CRMP4 in Gastric Cancer [Retraction]
Publicado: (2023)

MicroRNA-509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor
por: Hou, Chao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r3kcqg98o1rnt9g914ghre04d5